4//SEC Filing
Macomber Lori 4
Accession 0000950170-25-012326
CIK 0001503802other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:15 PM ET
Size
7.2 KB
Accession
0000950170-25-012326
Insider Transaction Report
Form 4
Macomber Lori
EVP, CFO & Treasurer
Transactions
- Award
Common Stock
2025-01-31+160,000→ 160,000 total - Award
Stock Option (right to buy)
2025-01-31+650,000→ 650,000 totalExercise: $0.62Exp: 2035-01-30→ Common Stock (650,000 underlying)
Footnotes (2)
- [F1]Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Inducement Stock Incentive Plan, as amended (the "Plan"). RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning January 31, 2026.
- [F2]This option was granted on January 31, 2025 pursuant to the Plan. The shares underlying this option vest as to 25% of the shares on January 31, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Karyopharm Therapeutics Inc.
CIK 0001503802
Entity typeother
Related Parties
1- filerCIK 0001968671
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:15 PM ET
- Size
- 7.2 KB